Evan Noch, M.D., Ph.D.
< Back to Search Results

Evan Noch, M.D., Ph.D.


Profile Photo of Evan Noch, M.D., Ph.D.
Gender: Male
Language: English


Personal Statement

Dr. Noch’s research focuses on the molecular mechanisms of endogenous tumor-associated necrosis in glioblastoma as well as the regulation of glucose metabolism using targeted therapies and dietary strategies to treat glioblastoma.  Within this research program, he uses patient-derived models of glioblastoma to better recapitulate the human disease state and employs a wide variety of available technologies and core facilities within the tri-institutional community.  He hopes to improve not only patient outcomes and survival but also overall well-being during treatment, particularly with respect to tumor necrosis that can be a devastating aspect of this tumor type and a major adverse effect of current treatment.


Specialties and Expertise


  • Neuro-Oncology


  • Brain Tumor
  • Brain Cancer
  • Glioblastoma
  • Oligodendroglioma
  • Medulloblastoma
  • Ependymoma
  • Primitive Neuroectodermal Tumor
  • Meningioma
  • Brain Metastases
  • Headache
  • Seizure
  • Neuropathy
  • Vertigo
  • Dizziness
  • Lower Back Pain
  • Neck Pain


Dr. Noch completed his undergraduate studies at New York University, where he obtained a Bachelor’s of Science degree in Neural Science. He then went on to complete his MD and PhD degrees at Temple University School of Medicine, where he studied the role of viral and cellular oncogenes in the regulation of oxygen and glucose metabolism in malignant brain tumors.  Returning to New York City, he completed his Internship in Internal Medicine and then Residency in Neurology at Weill Cornell Medicine under the Department of Neurology’s Residency Research Track funded by the Brain and Mind Research Institute Clinician-Scientist Fund.  He served as Chief Resident for Research during his third year of residency and Chief Resident for Research and Education during his fourth year.  He then completed his fellowship in Neuro-oncology at Memorial Sloan Kettering Cancer Center before transitioning back to Weill Cornell Medicine as an Instructor in the Department of Neurology.  During residency and fellowship, Dr. Noch has also been performing his post-doctoral studies in the laboratory of Dr. Lewis Cantley at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, where he has been using novel strategies to combine targeted therapy with dietary interventions to improve treatment of glioblastoma.


Honors and Awards

Honors and Awards

Dr. Noch is the recipient of numerous research-related awards, including the Florence Gloria Freedman Award for Cancer Research from Temple University School of Medicine, the Weill Cornell Medicine Department of Neurology Residency Research Award, and the Scholar-in-Training Award from the American Association for Cancer Research (AACR). He was also a selected trainee at the National Institute of Neurological Disorders and Stroke-sponsored Neurotherapeutics Drug Discovery and Development Workshop, the AACR Molecular Biology in Clinical Oncology Workshop, and the Society for Neuro-oncology Young Investigator’s Forum in Neuro-oncology.  He has been selected to present his work in oral and poster presentations at numerous workshops and meetings internationally.


Board Certifications

  • American Board of Psychiatry & Neurology
  • American Board of Psychiatry & Neurology
  • United Council for Neurologic Subspecialties (Behavioral Neurology & Neuropsychiatry)

Clinical and Academic Positions

  • Assistant Attending Neurologist - NewYork-Presbyterian Hospital
  • Assistant Professor of Neurology - Weill Cornell Medical College, Cornell University

Education and Training

  • M.D., Ph.D., Temple University, 2013
  • B.S., New York University, 2006


Insurance Plans Accepted

The following represents most of the managed care plans accepted by this doctor. If your insurance carrier does not appear here please contact the doctor’s office as they may have individual contracts not included on this site.

* indicates this doctor is no longer accepting new patients with this insurance plan.

  • AETNA - Medicare
  • Aetna Weill Cornell Employee Managed Care Plan
  • Aetna Weill Cornell Employee PPO Plan
  • Aetna-NYP - EPO/POS
  • Affinity Access
  • Affinity Health Plan
  • AgeWell New York
  • Amida Care
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield - Blue Access
  • Empire Blue Cross/Blue Shield - Blue Connection
  • Empire Blue Cross/Blue Shield - EPO
  • Empire Blue Cross/Blue Shield - HMO
  • Empire Blue Cross/Blue Shield - Mediblue (Senior)
  • Empire Blue Cross/Blue Shield - PPO
  • Empire Blue Cross/Blue Shield HealthPlus
  • Empire Blue Cross/Blue Shield HealthPlus - CHP
  • Fidelis Care
  • GHI - CBP
  • Health First
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) - Medicaid
  • Health Insurance Plan of NY (HIP) - Medicare
  • Medicaid
  • Medicare
  • Oxford Health Plans - Freedom
  • Oxford Health Plans - Liberty
  • Oxford Health Plans - Medicare Advantage
  • Oxford Health Plans - Metro/Core/Charter
  • Rockefeller University - Trustmark
  • United Empire
  • United Healthcare
  • United Healthcare - Community Plan
  • United Healthcare - Medicare
  • United Healthcare Compass
  • VNSNY CHOICE - Medicare
  • WellCare of NY
  • WorldWide Medical

Locations and Appointments

News and Media

External Relationships

External Relationships

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

LEXEO Therapeutics, Inc.
Leadership Roles:
Destroke, Inc.
Destroke, Inc.
Proprietary Interest:
Destroke, Inc.